It has been reported that adjunctive IL2 treatment of drug-sensitive TB patients in combination with multiple sensitive anti-TB drugs (antibiotics) failed to uncover IL2 therapeutic effect [12], despite that other studies clearly demonstrated that IL2 can control TB infection [8]. This evidence concerns the gene IL2 and tuberculosis.